Lv11
60 积分 2023-02-28 加入
Recovery-model: A model for CAR T-cell-related thrombocytopenia in relapsed/refractory multiple myeloma
12小时前
待确认
Multiple myeloma
1个月前
已完结
GPRC5D-Targeted CAR T Cells for Myeloma. Reply
11个月前
已完结
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
11个月前
已完结
Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial
1年前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
1年前
已完结
皖公网安备34019202002308
